What Do We Mean by Validation of a Measure?
Successful COAs: It all starts with the “concept of interest” and “context of use”
Feb. 20, 2019 - This webinar featured T. Rosie Love, MPH, University of Maryland School of Pharmacy, Dept. Pharmaceutical Health Services Research
Clinical Outcome Assessment Webinar Series: Untangling the Terms: Endpoints, Items, Outcomes, PRO’s, PROMs, PRO-PMs
Jan. 17, 2019 - This webinar featured Ashley F. Slagle, MS, PhD, Principal, Aspen Consulting, LLC.
FDA’s Roadmap to Patient-Focused Outcome Measurement in Clinical Trials
Dec. 7, 2018 - In patient-centered research and care, we focus on the outcomes most important to patients. Often, patients tell us that what is most important to them is how they feel and how well they function in their everyday lives. To capture data on these outcomes in clinical trials, measures must first be developed. This webinar introduces participants to a document, the Roadmap, developed by the Clinical Outcome Assessment (COA) team at the Food and Drug Administration. The Roadmap helps researchers develop tools that measure outcomes that matter most to patients.
Patient Reported Outcomes and Patient Centered Outcomes
Nov. 7, 2018 - In patient-centered research and care, we focus on the outcomes most important to patients. Often, patients tell us that what is most important to them is how they feel and how well they function in their everyday lives. These outcomes are referred to in research as patient-reported outcomes or PROs. So, what is the difference between a patient-centered outcome and a patient-reported outcome? Are they the same? The answer is: No, they are not the same! In this webinar, presented by Dr. Eleanor Perfetto, you will learn about the difference between patient-centered outcomes and patient-reported outcomes, and why we need patient-centered PROs in research and care.
IRS Policy on High-Deductible Health Plans Impacting Americans with Chronic Conditions
The NHC hosted a webinar on June 26, 2018 with top value-based insurance-design expert Dr. A. Mark Fendrick. The one-hour webinar focused on a recent study that examines how current IRS policy on high-deductible health plans (HDHPs) and health savings accounts (HSAs) impacts Americans living with chronic conditions. Dr. Fendrick presented findings of the study and participated in an audience question-and-answer session. This webinar was sponsored by the National Pharmaceutical Council. Dr. Mark Fendrick is the Director, University of Michigan Center for Value-Based Insurance Design and a Professor of Internal Medicine in the School of Medicine and a Professor of Health Management and Policy in the School of Public Health at the University of Michigan.
Three-part webinar series on Patient Engagement in Value Assessment
- Part 1: An Overview of Value Frameworks
- Part 2: Introduction to Health Economics & Value Assessment
- Part 3: How the Patient Community Can & Should Be Engaged
Three-part webinar series on Alternative Payment Models
As innovative payment models continue to evolve and transform the US health care system, patients must be engaged and activated. This webinar series is specifically developed for the patient community.